1,244
Views
30
CrossRef citations to date
0
Altmetric
Clinical Studies

Superior Outcome of Nafamostat Mesilate as an Anticoagulant in Patients Undergoing Maintenance Hemodialysis with Intracerebral Hemorrhage

, , , , , & show all
Pages 668-675 | Received 08 Apr 2009, Accepted 17 May 2009, Published online: 09 Oct 2009

REFERENCES

  • Iseki K, Fukiyama K. Okawa Dialysis Study (OKIDS) Group. Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis. The Okinawa Dialysis Study (OKIDS) Group. Nephrol Dial Transplant. Nov2000;15(11):1808–1813.
  • Toyoda K, Fujii K, Fujimi S, Kumai Y, Tsuchimochi H, Ibayashi S, Iida M. Stroke in patients on maintenance hemodialysis: A 22-year single-center study. Am J Kidney Dis. Jun2005;45(6):1058–1066.
  • Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJ, Briët E, Büller HR. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints. Lancet. Dec 41999;354(9194):1940–1947.
  • Zhang Z, Nagata I, Kikuchi H, Xue JH, Sakai N, Sakai H, Yanamoto H. Broad-spectrum and selective serine protease inhibitors prevent expression of platelet-derived growth factor-BB and cerebral vasospasm after subarachnoid hemorrhage: Vasospasm caused by cisternal injection of recombinant platelet-derived growth factor-BB. Stroke. Jul2001;32(7):1665–1672.
  • Deitch EA, Shi HP, Lu Q, Feketeova E, Xu DZ. Serine proteases are involved in the pathogenesis of trauma-hemorrhagic shock-induced gut and lung injury. Shock. May2003;19(5):452–456.
  • Fischer KG. Essentials of anticoagulation in hemodialysis. Hemodial Int. Apr2007;11(2):178–189.
  • Hedges SJ, Dehoney SB, Hooper JS, Amanzadeh J, Busti AJ. Evidence-based treatment recommendations for uremic bleeding. Nat Clin Pract Nephrol. Mar2007;3(3):138–153.
  • Weigert AL, Schafer AI. Uremic bleeding: Pathogenesis and therapy. Am J Med Sci. Aug1998;316(2):94–104.
  • Murase M, Usui A, Tomita Y, Maeda M, Koyama T, Abe T. Nafamostat mesylate reduces blood loss during open heart surgery. Circulation. Nov1993;88(5 Pt 2):II432–II436.
  • Lin CL, Kwan AL, Howng SL. Prognosis of spontaneous intracerebral hemorrhage in hemodialysis patients. Kaohsiung J Med Sci. Aug1999;15(8):484–490.
  • Murakami M, Hamasaki T, Kimura S, Maruyama D, Kakita K. Clinical features and management of intracranial hemorrhage in patients undergoing maintenance dialysis therapy. Neurol Med Chir (Tokyo). May2004;44(5):225–232.
  • Kawamura M, Fijimoto S, Hisanaga S, Yamamoto Y, Eto T. Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. Am J Kidney Dis. Jun1998;31(6):991–996.
  • Iseki K, Fukiyama K. Predictors of stroke in patients receiving chronic hemodialysis. Kidney Int. Nov1996;50(5):1672–1675.
  • Iseki K, Kinjo K, Kimura Y, Osawa A, Fukiyama K. Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int. Nov1993;44(5):1086–1090.
  • Onoyama K, Ibayashi S, Nanishi F, Okuda S, Oh Y, Hirakata H, Nishimura Y, Fujishima M. Cerebral hemorrhage in patients on maintenance hemodialysis. CT analysis of 25 cases. Eur Neurol. 1987;26(3):171–175.
  • Miyahara K, Murata H, Abe H. Predictors of intracranial hematoma enlargement in patients undergoing hemodialysis. Neurol Med Chir (Tokyo). Feb2007;47(2):47–51.
  • Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke. Dec1997;28(12):2370–2375.
  • Fujii Y, Tanaka R, Takeuchi S, Koike T, Minakawa T, Sasaki O. Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg. Jan1994;80(1):51–57.
  • Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke. 1998;29(6):1160–1166 Jun.
  • Shin PJ, Han BG, Yoon HJ, Kim JS, Kim MH, Karl EH, Whang K, Choi SO. Clinical features of stroke in patients undergoing maintenance dialysis. Korean J Nephrol. 2000;19:884–890.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.